Peng Pan
VICE PRESIDENT, PRECLINICAL

Peng Pan, PhD

Peng Pan, PhD joined Mythic Therapeutics in September 2023 to lead the development and execution of the company’s nonclinical and translational development efforts for its ADC candidates, from lead identification through health authority marketing application and approval.

Before Mythic, Peng was Senior Director and Head of Bioanalytical Sciences at EQRx, where he established and led the Bioanalytical Sciences Group covering bioanalysis, immunogenicity and safety assessments, and biomarker strategy to support all EQRx preclinical and clinical programs. Before that, Peng served as Director of DMPK and Bioanalytical Sciences at GSK, Bioanalytical and Biomarker Lead at Shire, and Senior Scientist in Global Biotherapeutics Development at Sanofi Genzyme.

Peng received his PhD in Analytical Chemistry from Purdue and completed an Abbott Innovation Foundation Postdoctoral Fellowship at Abbott Laboratories.